Media update, page-2182

The time horizon on projects is also an important regional differentiator. In the US and Europe, years often pass between the first conversation and the implementation of water treatment systems. Ari Raivetz, CEO of Organica Water, cited a 6-7 year sales process in the US, compared to 18-24 months in China. Ari estimates that 80% of projects in China are run by a single company that finances, builds, owns and operates a plant. This company will then be focused on the CAPEX returns of these facilities, as well as the OPEX reductions, incentivizing the integration of innovative new technologies.

Thanks very much for the article.

We have seen this phenomena unfold. Hence, EMC first launched MABR in China in 2016 rather than ROW. Article says it takes 18-24 months sales process in China. Again, proven true. Launched in 2016, and only now in 2018, do we see Hubei iTest making bulk orders.

Dow Chemical and Saudi Aramco have both invested in OxyMem as strategic partners, providing capital and contacts within adjacent markets, such as chemicals and oil & gas. This type of strategic relationship also allows corporates to gain a deeper understanding of the innovator’s technology, how it applies to their business, and the dynamics of areas in the value chain where there is less institutional knowledge – both Dow and Saudi Aramco will gain insights into industrial water market dynamics through working with OxyMem.

FLC took the big bet of entering Aspiral via the municipal market, not the industrial market as Oxymem did as the article suggests. The market must be sitting up and looking at iTest and their 80 sites and wonder, darn, why didn't we see the scale coming from there? I think the whole complexion of how the market sees FLC has changed since the iTest announcement.

@Relax1, appreciate your thoughts.